Senate Hearing on FDA User Fee Agreements
January 1, 2018
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
The Frame
The hearing addresses the funding mechanism for the FDA, which directly impacts the speed and safety standards by which new medical drugs and devices are approved for public use.
Potentially affected actors named in the source documents. Mention is not a position.
Food and Drug Administration (FDA)
The agency receives funding through user fee agreements to conduct regulatory reviews.
Medical product manufacturers
These companies pay user fees to the FDA as part of the product approval process.
Patients
Patients are affected by the speed and safety standards of the medical product approval process.
Last recorded activity January 1, 2018.
Next step not available in the current record.
Summary
Key Facts
- The hearing was held on March 21, 2017, by the Senate Committee on Health, Education, Labor, and Pensions.
- The primary subject is the reauthorization and implementation of FDA User Fee Agreements for drugs and medical devices.
- User fees are a funding source for the FDA to manage the regulatory process for medical products.
- The hearing follows the passage of the 21st Century Cures Act, which aimed to accelerate the medical product approval process.
- Witnesses included directors from the FDA's Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, and Center for Devices and Radiological Health.
Frequently Asked Questions
What are FDA User Fee Agreements?
Why is this hearing important for patients?
Why It Matters
The hearing addresses the funding mechanism for the FDA, which directly impacts the speed and safety standards by which new medical drugs and devices are approved for public use.
News Coverage
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Post-Cures Act Implementation
The hearing explicitly links the FDA user fee process to the implementation of the 21st Century Cures Act, showing a legislative intent to tie funding to faster regulatory timelines.
Connected Entities
Sources
www.govinfo.gov
Analysis Score
0–100- Significance75How much this matters to a regular citizen
- Controversy20Intensity of disagreement among stakeholders
- Entertainment10Compellingness for a non-policy-wonk reader
- Buzz15Current news / social attention level
Publisher tools